The Cardiovascular Impact of COVID-19

The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents the greatest medical challenge in decades. While COVID-19 primarily affects the lungs, causing interstitial pneumonitis and severe acute respiratory distress syndrome (ARDS), it also affects multiple organs, particularly the cardiovascular system. Risk of severe infection and mortality increase with advancing age and male sex. Mortality is increased by comorbidities: cardiovascular disease, hypertension, diabetes, chronic pulmonary disease, and cancer. The most common complications include arrhythmia , cardiac injury, fulminant myocarditis, heart failure, pulmonary embolism, and disseminated intravascular coagulation (DIC).

 

 

  • Cardiac stress test
  • Cardiac ventriculography
  • Positron emission photography
  • Tilt table test
  • Radionucleide angiography
  • Phonocardiogram
  • Computed tomography angiography

Related Conference of The Cardiovascular Impact of COVID-19

October 20-21, 2025

39th World Congress on Heart Diseases

Frankfurt, Germany
November 13-14, 2025

6th Global Summit on Heart Congress

Paris, France
November 19-20, 2025

7th World Heart Congress

Tokyo, Japan
November 24-25, 2025

36th Annual Cardiologists Conference

Barcelona, Spain
November 27-28, 2025

32nd World Heartcare Summit

Paris, France
January 12-13, 2026

12th International Heart Conference

Dubai, UAE
March 18-19, 2026

15th World Heart Congress

Paris, France
March 23-24, 2026

41st World Cardiology Conference

London, UK
April 08-29, 2026

9th Annual Heart Rhythm Conference

Vienna, Austria
April 13-14, 2026

9th World Heart and Brain Conference

Tokyo, Japan
May 14-15, 2026

5th International Conference on Cardiology

Rome, Italy
May 21-22, 2026

15th World Congress on Cardiology

London, UK
July 29-30, 2026

30th World Cardiology Conference

Paris, France

The Cardiovascular Impact of COVID-19 Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in